The fibromyalgia tender points: Use them or lose them? A brief review of the controversy

Journal of Rheumatology

Volumn 34, Issue 5, 2007, Pages 914-922

  Harth, Manfred ^a,c   Nielson, Warren R ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ST JOSEPH S HEALTH CENTRE   (Canada)

^c AIM Health Group   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC TEST; EDITORIAL; FATIGUE; FIBROMYALGIA; HUMAN; MUSCULOSKELETAL PAIN; PATHOGENESIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

DIAGNOSTIC TECHNIQUES AND PROCEDURES; FIBROMYALGIA; HUMANS; HYPERALGESIA; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PRESSURE; REPRODUCIBILITY OF RESULTS; RHEUMATOLOGY;

EID: 34248653455     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (83)

1. Simons DG. Muscle pain syndromes. Part I. Am J Phys Med 1975;54:289-311.
2. Simons DG. Muscle pain syndromes. Part II. Am J Phys Med 1976;55:15-42.
3. Inanici F, Yunus MB. History of fibromyalgia: past to present. Curr Pain Headache Rep 2004;8:369-78.
4. Smythe HA, Moldofsky H. Two contributions to understanding of the "fibrositis" syndrome. Bull Rheum Dis 1977-8;28:928-31.
5. Yunus M, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched controls. Semin Arthritis Rheum 1981;11:151-71.
6. Campbell SM, Clark S, Tindall EA, Forehand ME, Bennett RM. Clinical characteristics of fibrositis. I. A "blinded," controlled study of symptoms and tender points. Arthritis Rheum 1983;26:817-24.
7. Lautenschlager J, Bruckle W, Schnorrenberger CC, Muller W. Measuring pressure pain of tendons and muscles in healthy probands and patients with generalized tendomyopathy (fibromyalgia syndrome). Z Rheumatol 1988;47:397-404.
8. Yunus MB, Masi AT, Aldag JC. Preliminary criteria for primary fibromyalgia syndrome (PFS): multivariate analysis of a consecutive series of PFS, other pain patients, and normal subjects. Clin Exp Rheumatol 1989;7:63-9.
9. Samborski W, Stratz T, Sobieska M, Mennet P, Muller W. Pressure point studies in generalized tendomyopathy (fibromyalgia) (comparison of various methods). Z Rheumatol 1991;50:382-6.
10. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
11. Schochat T, Croft P, Raspe H. The epidemiology of fibromyalgia. Workshop of the Standing Committee on Epidemiology, European League Against Rheumatism (EULAR), Bad Sackingen, 19-21 November 1992. Br J Rheumatol 1994;33:783-6.
12. Croft P, Schollum J, Silman A. Population study of tender point counts and pain as evidence of fibromyalgia. BMJ 1994;309:696-9.
13. Schochat T, Raspe H. Elements of fibromyalgia in an open population. Rheumatology Oxford 2003;42:829-35.
14. Wolfe F. The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 1997;56:268-71.
15. Katz RS, Wolfe F, Michaud K. Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis Rheum 2006;54:169-76.
16. Hughes G, Martinez C, Myon E, Taieb C, Wessely S. The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 2006;54:177-83.
17. White KP, Harth M, Speechley M, Ostbye T. A general population study of fibromyalgia tender points in noninstitutionalized adults with chronic widespread pain. J Rheumatol 2000;27:2677-82.
18. Tunks E, Crook J, Norman G, Kalaher S. Tender points in fibromyalgia. Pain 1988;34:11-9.
19. Granges G, Littlejohn G. Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum 1993;36:642-6.
20. Wolfe F. What use are fibromyalgia control points? J Rheumatol 1998;25:546-50.
21. Cott A, Parkinson W, Bell MJ, et al. Interrater reliability of the tender point criterion for fibromyalgia. J Rheumatol 1992;19:1955-9.
22. Tunks E, McCain GA, Hart LE, et al. The reliability of examination for tenderness in patients with myofascial pain, chronic fibromyalgia and controls. J Rheumatol 1995;22:944-52.
23. Smythe HA, Gladman A, Dagenais P, Kraishi M, Blake R. Relation between fibrositic and control site tenderness; effects of dolorimeter scale length and footplate size. J Rheumatol 1992;19:284-9.
24. Okifuji A, Turk DC, Sinclair JD, Starz TW, Marcus DA. A standardized manual tender point survey. I. Development and determination of a threshold point for the identification of positive tender points in fibromyalgia syndrome. J Rheumatol 1997;24:377-83.
25. Hapidou EG, Rollman GB. Menstrual cycle modulation of tender points. Pain 1998;77:151-61.
26. Bellamy N, Sothern RB, Campbell J. Aspects of diurnal rhythmicity in pain, stiffness, and fatigue in patients with fibromyalgia. J Rheumatol 2004;31:379-89.
27. Croft P, Rigby AS, Boswell R, Schollum J, Silman A. The prevalence of chronic widespread pain in the general population. J Rheumatol 1993;20:710-3.
28. Lindell L, Bergman S, Petersson IF, Jacobsson LT, Herrstrom P. Prevalence of fibromyalgia and chronic widespread pain. Scand J Prim Health Care 2000;18:149-53.
29. Huppe A, Brockow T, Raspe H. Chronic widespread pain and tender points in low back pain: a population-based study. Z Rheumatol 2004;63:76-83.
30. Urrows S, Affleck G, Tennen H, Higgins P. Unique clinical and psychological correlates of fibromyalgia tender points and joint tenderness in rheumatoid arthritis. Arthritis Rheum 1994;37:1513-20.
31. Lautenbacher S, Rollman GB, McCain GA. Multi-method assessment of experimental and clinical pain in patients with fibromyalgia. Pain 1994;59:45-53.
32. Kosek E, Ekholm J, Hansson P. Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain 1996;68:375-83.
33. Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001;91:165-75.
34. Gracely RH, Grant MA, Giesecke T. Evoked pain measures in fibromyalgia. Best Pract Res Clin Rheumatol 2003;17:593-609.
35. Desmeules JA, Cedraschi C, Rapiti E, et al. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 2003;48:1420-9.
36. Carli G, Suman AL, Biasi G, Marcolongo R. Reactivity to superficial and deep stimuli in patients with chronic musculoskeletal pain. Pain 2002;100:259-69.
37. Wolfe F, Skevington SM. Measuring the epidemiology of distress: the rheumatology distress index. J Rheumatol 2000;27:2000-9.
38. Petzke F, Gracely RH, Park KM, Ambrose K, Clauw DJ. What do tender points measure? Influence of distress on 4 measures of tenderness. J Rheumatol 2003;30:567-74.
39. McCarberg B, Barkin RL, Wright JA, Cronan TA, Groessl E, Schmidt SM. Tender points as predictors of distress and the pharmacologic management of fibromyalgia syndrome. Am J Ther 2003;10:176-92.
40. Staud R, Vierck CJ, Robinson ME, Price DD. Overall fibromyalgia pain is predicted by ratings of local pain and pain-related negative affect - possible role of peripheral tissues. Rheumatology Oxford 2006;45:1409-15.
41. Pamuk ON, Yesil Y, Çakir N. Factors that affect the number of tender points in fibromyalgia and chronic widespread pain patients who did not meet the ACR 1990 criteria for fibromyalgia: are tender points a reflection of neuropathic pain? Semin Arthritis Rheum 2006;36:130-4.
42. Porter-Moffitt S, Gatchel RJ, Robinson RC, et al. Biopsychosocial profiles of different pain diagnostic groups. J Pain 2006;7:308-18.
43. Hudson JI, Pope HG Jr. Fibromyalgia and psychopathology: is fibromyalgia a form of "affective spectrum disorder"? J Rheumatol 1989;16 Suppl 19:15-22.
44. Katz RS, Kravitz HM. Fibromyalgia, depression, and alcoholism: a family history study. J Rheumatol 1996;23:149-54.
45. Hudson JI, Arnold LM, Keck PE Jr, Auchenbach MB, Pope HG Jr. Family study of fibromyalgia and affective spectrum disorder. Biol Psychiatry 2004;56:884-91.
46. Nielson WR, Merskey H. Psychosocial aspects of fibromyalgia. Curr Pain Headache Rep 2001;5:330-7.
47. Raphael K, Malvin NJ, Sangeetha N, Schwartz JE, Gallagher RM. Familial aggregation of depression in fibromyalgia: a community-based test of alternate hypotheses. Pain 2004;110:449-60.
48. Ahles TA, Khan SA, Yunus MB, Spiegel DA, Masi AT. Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: a blind comparison of DSM-III diagnoses. Am J Psychiatry 1991;148:1721-6.
49. Malt EA, Berle JE, Olafsson S, Lund A, Ursin H. Fibromyalgia is associated with panic disorder and functional dyspepsia with mood disorders. J Psychosom Res 2000;49:285-9.
50. Giesecke T, Gracely RH, Williams DA, Geisser ME, Petzke FW, Clauw DJ. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum 2005;52:1577-84.
51. Raphael KG, Janal MN, Nayak S, Schwartz JE, Gallagher RM. Psychiatric comorbidities in a community sample of women with fibromyalgia. Pain 2006;124:117-25.
52. Sharp TJ, Harvey AG. Chronic pain and posttraumatic stress disorder: mutual maintenance? Clin Psychol Rev 2001;21:857-77.
53. Macfarlane GJ, Croft PR, Schollum K, Silman AJ. Widespread pain: is an improved classification possible? J Rheumatol 1996;23:1628-32.
54. Sheehy C, Murphy E, Barry M. Depression in rheumatoid arthritis - underscoring the problem. Rheumatology Oxford 2006;45:1325-7.
55. Quinter JL, Cohen ML. Fibromyalgia falls foul of a fallacy. Lancet 1999;353:1092-4.
56. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
57. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
58. Russell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994;37:1593-601.
59. Giovengo SL, Russell IJ, Larson AA. Increased concentrations of nerve growth factor in cerebrospinal fluids of patients with fibromyalgia. J Rheumatol 1999;26:1564-9.
60. Bradley LA, McKendree-Smith NL, Alberts KR, Alarcon GS, Mountz JM, Deutsch G. Use of neuroimaging to understand abnormal pain sensitivity in fibromyalgia. Curr Rheumatol Rep 2000;2:141-8.
61. Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002;45:1333-43.
62. Cook DB, Lange G, Ciccone DS, Liu WC, Steffener J, Natelson BH. Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 2004;31:364-78.
63. Clauw DJ, Crofford LJ. Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Pract Res Clin Rheumatol 2003;17:685-701.
64. Russell IJ. Is fibromyalgia a distinct clinical entity? The clinical investigator's evidence. Baillieres Best Pract Res Clin Rheumatol 1999;13:445-54.
65. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72.
66. Khostanteen I, Tunks ER, Goldsmith CH, Ennis J. Fibromyalgia: can one distinguish it from simulation? An observer-blind controlled study. J Rheumatol 2000;27:2671-6.
67. Marques AP, Ferreira EA, Matsutani LA, Pereira CA, Assumpcao A. Quantifying pain threshold and quality of life of fibromyalgia patients. Clin Rheumatol 2005;24:266-71.
68. Vierck CJ Jr. Mechanisms underlying development of spatially distributed chronic pain (fibromyalgia). Pain 2006;124:242-63. E-pub 2006 Jul 13.
69. McIntosh MJ, Hewett JE, Buckelew SP, Conway RR, Rossy LA. Protocol for verifying expertise in locating fibromyalgia tender points. Arthritis Care Res 1998;11:210-6.
70. Wolfe F. Stop using the American College of Rheumatology criteria in the clinic. J Rheumatol 2003;30:1671-2.
71. Hagen KB, Kvien TK, Bjorndal A. Musculoskeletal pain and quality of life in patients with noninflammatory joint pain. J Rheumatol 1997;24:1703-9.
72. Buskila D, Abramov G, Biton A, Neumann L. The prevalence of pain complaints in a general population in Israel and its implications for utilization of health services. J Rheumatol 2000;27:1521-5.
73. White KP, Speechley M, Harth M, Ostbye T. The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J Rheumatol 1999;26:1577-85.
74. White KP, Speechley M, Harth M, Ostbye T. Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario: the London Fibromyalgia Epidemiology Study. Arthritis Rheum 1999;42:76-83.
75. White KP, Nielson WR, Harth M, Ostbye T, Speechley M. Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample. J Rheumatol 2002;29:588-94.
76. Wolfe F. Pain extent and diagnosis: development and validation of the regional pain scale in 12,799 patients with rheumatic disease. J Rheumatol 2003;30:369-78.
77. Fitzcharles MA, Boulos P. Inaccuracy in the diagnosis of fibromyalgia. Rheumatology Oxford 2003;42:263-7.
78. Price DD, Staud R. Neurobiology of fibromyalgia syndrome. J Rheumatol 2005;32 Suppl 75:22-8.
79. Harris RE, Gracely RH, McLean SA, et al. Comparison of clinical and evoked pain measures in fibromyalgia. J Pain 2006;7:521-7.
80. Bennett R. Fibromyalgia: Present to future. Curr Pain Headache Rep 2004;8:379-84.
81. Mease PJ, Clauw DJ, Arnold LM, et al. Fibromyalgia syndrome. J Rheumatol 2005;32:2270-7.
82. Arnold LM, Lu Y, Crofford LJ, et al. A double-blind multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004;50:2974-84.
83. Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991;18:728-33.